Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 2 | 2022 | 66 | 1.230 |
Why?
|
| Krukenberg Tumor | 1 | 2022 | 2 | 0.770 |
Why?
|
| Carcinoma, Lobular | 1 | 2022 | 21 | 0.750 |
Why?
|
| Genital Neoplasms, Female | 1 | 2022 | 15 | 0.750 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2022 | 3 | 0.740 |
Why?
|
| Carcinoma, Medullary | 1 | 2022 | 5 | 0.740 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2022 | 13 | 0.730 |
Why?
|
| Parotid Neoplasms | 1 | 2022 | 14 | 0.730 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 375 | 0.730 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 78 | 0.710 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2021 | 2 | 0.710 |
Why?
|
| Papanicolaou Test | 1 | 2021 | 8 | 0.710 |
Why?
|
| Hysterectomy | 1 | 2021 | 25 | 0.700 |
Why?
|
| Neuroendocrine Tumors | 1 | 2022 | 50 | 0.700 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 30 | 0.690 |
Why?
|
| Pleural Effusion | 1 | 2019 | 12 | 0.610 |
Why?
|
| Blastomycosis | 1 | 2019 | 19 | 0.600 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 41 | 0.590 |
Why?
|
| Umbilicus | 1 | 2018 | 2 | 0.560 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 5 | 0.550 |
Why?
|
| Endometriosis | 1 | 2018 | 15 | 0.550 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 24 | 0.540 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 103 | 0.500 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 200 | 0.490 |
Why?
|
| Retrospective Studies | 7 | 2022 | 2985 | 0.420 |
Why?
|
| Adult | 7 | 2021 | 6921 | 0.380 |
Why?
|
| Female | 9 | 2022 | 12934 | 0.370 |
Why?
|
| Middle Aged | 7 | 2021 | 7911 | 0.360 |
Why?
|
| Humans | 11 | 2022 | 22903 | 0.330 |
Why?
|
| Urine | 2 | 2021 | 7 | 0.330 |
Why?
|
| Aged | 6 | 2021 | 7435 | 0.300 |
Why?
|
| Male | 6 | 2021 | 12453 | 0.230 |
Why?
|
| Young Adult | 2 | 2021 | 1651 | 0.230 |
Why?
|
| Adolescent | 2 | 2021 | 1880 | 0.230 |
Why?
|
| Cytodiagnosis | 2 | 2021 | 18 | 0.210 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2021 | 33 | 0.200 |
Why?
|
| Fibroadenoma | 1 | 2022 | 6 | 0.190 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 12 | 0.190 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2022 | 31 | 0.190 |
Why?
|
| Endolymphatic Sac | 1 | 2022 | 2 | 0.190 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2022 | 4 | 0.190 |
Why?
|
| Ear Neoplasms | 1 | 2022 | 5 | 0.180 |
Why?
|
| Parotid Gland | 1 | 2022 | 17 | 0.180 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 63 | 0.180 |
Why?
|
| Curettage | 1 | 2021 | 9 | 0.180 |
Why?
|
| Cervix Uteri | 1 | 2021 | 12 | 0.180 |
Why?
|
| Adenoma | 1 | 2022 | 58 | 0.170 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 18 | 0.170 |
Why?
|
| Biopsy | 1 | 2021 | 188 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 118 | 0.170 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 442 | 0.160 |
Why?
|
| Streptococcus agalactiae | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cystitis | 1 | 2019 | 11 | 0.150 |
Why?
|
| Hematuria | 1 | 2019 | 14 | 0.150 |
Why?
|
| Sex Factors | 1 | 2019 | 387 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 102 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 3720 | 0.130 |
Why?
|
| Incidence | 1 | 2019 | 624 | 0.130 |
Why?
|
| Age Factors | 1 | 2019 | 636 | 0.130 |
Why?
|
| Risk Factors | 1 | 2019 | 1971 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2022 | 72 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 311 | 0.040 |
Why?
|